Treatment of childhood-onset hearing loss can be more precisely tailored with information on specific genetic cause.
Dr. Danny E. Miller hopes to advance new sequencing technologies to solve undiagnosed genetic disorders.
Findings suggest men undergoing cancer-risk genetic testing should be tested for mutations in this gene as well.
These National Institutes of Health grants will support trailblazing ideas for solving critical questions in biomedical science.
A national partnership, funded by the NIH, will evaluate the use of genomic information in the health care of diverse participants
There is currently no way to detect ovarian cancer early. But genetic testing enables doctors to identify a person's risk and may help prevent the cancer.
The National Cancer Institute will fund research of how screenings in that environment affect patient outcomes and health systems’ resources.
Names that label certain cancer risk genes as sex- or organ-specific can dissuade people who need to be tested, according to Nature commentary.
Screening of healthy adults for genes that might heighten disease risk must be pursued cautiously, concludes a U.S. panel whose authors include a UW bioethicist.
Findings on nearly 4,000 BRCA1 mutations will be immediately useful to many patients with previously inconclusive genetic test results.